Shuichiro Neshige Selected Research

Shuichiro Neshige Research Topics

Disease

4	Seizures (Absence Seizure) 11/2021 - 12/2015
4	Epilepsy (Aura) 10/2021 - 01/2018
2	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 01/2022
2	Myoclonus (Nocturnal Myoclonus) 01/2022 - 10/2019
2	Encephalitis (Encephalitis, Rasmussen) 10/2021 - 11/2020
2	Neoplasms (Cancer) 10/2021 - 01/2014
1	Temporal Lobe Epilepsy 04/2022
1	Generalized Epilepsy 11/2021
1	Carcinoma (Carcinomatosis) 10/2021
1	Unverricht-Lundborg Syndrome (Disease, Unverricht) 10/2021
1	Autoimmune Diseases of the Nervous System 10/2021
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 10/2021
1	Parkinsonian Disorders (Parkinsonism) 08/2021
1	Stupor 03/2021
1	Glioma (Gliomas) 11/2020
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 06/2020
1	Amnesia (Dissociative Amnesia) 06/2020
1	Disease Progression 06/2020
1	Partial Epilepsies (Epilepsy, Partial) 01/2019
1	Ischemic Stroke 06/2017
1	Anisocoria 01/2017
1	Embolic Stroke 05/2016
1	Myocardial Infarction 05/2016
1	Avitaminosis (Vitamin Deficiency) 01/2016
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2016
1	Hyperhomocysteinemia 01/2016
1	Cerebral Hemorrhage 12/2015
1	Thrombophilia 09/2015
1	Stroke (Strokes) 09/2015
1	Infections 01/2015
1	Abscess 01/2015
1	Brain Diseases (Brain Disorder) 01/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Reinfection 01/2015
1	Mumps 01/2015
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2014
1	Kidney Diseases (Kidney Disease) 01/2014
1	Hyperuricemia 01/2014
1	Neurologic Manifestations (Neurological Manifestations) 01/2014

Drug/Important Bio-Agent (IBA)

3	Levetiracetam (Keppra)FDA LinkGeneric 04/2022 - 11/2021
2	Anticonvulsants (Antiepileptic Drugs)IBA 11/2021 - 12/2015
2	perampanelIBA 10/2021 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2014
1	Lacosamide FDA Link 11/2021
1	Pharmaceutical PreparationsIBA 11/2021
1	Valproic Acid (Depakote)FDA LinkGeneric 11/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	pembrolizumabIBA 10/2021
1	LigandsIBA 10/2021
1	Nicotine FDA Link 08/2021
1	Carbon DioxideIBA 03/2021
1	Leucine (L-Leucine)FDA Link 11/2020
1	TeaIBA 06/2020
1	SteroidsIBA 06/2020
1	Hemoglobins (Hemoglobin)IBA 06/2017
1	Mydriatics (Cycloplegics)IBA 01/2017
1	AnticoagulantsIBA 05/2016
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016
1	HomocysteineIBA 01/2016
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2016
1	Fibrinogen (Factor I)FDA Link 09/2015
1	AlbuminsIBA 09/2015
1	fibrin fragment D (D-dimer)IBA 09/2015
1	CholesterolIBA 09/2015
1	Riluzole FDA LinkGeneric 01/2015
1	AntibodiesIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	Metronidazole (Metric)FDA LinkGeneric 01/2015
1	Immunoglobulin M (IgM)IBA 01/2015
1	Estrogen ReceptorsIBA 01/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2014
1	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2014
1	EnzymesIBA 01/2014
1	Adenine PhosphoribosyltransferaseIBA 01/2014

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2015
2	Electrodes (Electrode) 01/2019 - 01/2018
1	Critical Care (Surgical Intensive Care) 01/2022
1	Aftercare (After-Treatment) 10/2021
1	Immunotherapy 10/2021
1	Implanted Electrodes 11/2019
1	Activities of Daily Living (ADL) 10/2019
1	Catheters 01/2015